Related Experiment Video
Updated: May 28, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Threshold virus dynamics with impulsive antiretroviral drug effects
Jie Lou1, Yijun Lou, Jianhong Wu
1Department of Mathematics, Shanghai University, 99 Shangda Road, Shanghai 200444, People's Republic of China.
Journal of Mathematical Biology
|October 12, 2011
Summary
This study analyzes nonlinear virus dynamics models with impulsive drug effects. The findings highlight that second-line antiviral treatment programs are crucial for rapid virus elimination, surpassing first-line programs where drug-resistant strains may dominate.
Area of Science:
- Mathematical Biology
- Virology
- Pharmacokinetics
Background:
- Understanding within-host virus dynamics is critical for effective treatment strategies.
- Impulsive drug effects and drug resistance significantly complicate viral clearance.
- Current treatment guidelines require rigorous analysis to optimize outcomes.
Purpose of the Study:
- To develop a mathematical framework for analyzing virus dynamics under impulsive drug treatment.
- To assess the efficacy of antiviral treatment protocols, specifically the Manuals of National AIDS Free Antiviral Treatment in China.
- To investigate conditions favoring virus clearance versus persistence, considering both wild-type and drug-resistant viral strains.
Main Methods:
- Development of an impulsive system of differential equations to model virus dynamics.
- Derivation of threshold parameters using concepts from periodic epidemic models and discrete dynamical systems.
- Numerical simulations to illustrate theoretical dynamics and evaluate treatment scenarios.
Main Results:
- First-line treatment programs may lead to the dominance of drug-resistant viral strains.
- Second-line treatment programs demonstrate potential for rapid elimination of both viral strains.
- Threshold dynamics predict virus clearance or persistence based on treatment parameters.
Conclusions:
- The timing and nature of antiviral interventions significantly impact treatment success.
- Second-line treatment programs offer a more effective strategy for achieving virus clearance.
- Early implementation of optimized treatment regimens is essential to combat viral persistence and resistance.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...